Find information on thousands of medical conditions and prescription drugs.

Visudyne

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
Hydrocodone
Vagifem
Valaciclovir
Valcyte
Valganciclovir
Valine
Valium
Valnoctamide
Valproate semisodium
Valproic acid
Valpromide
Valrelease
Valsartan
Valstar
Valtrex
Vancenase
Vanceril
Vancomycin
Vaniqa
Vanticon
Vecuronium bromide
Velcade
Velivet
Venlafaxine
Ventolin
Vepesid
Verapamil
Verelan
Vermox
Versed
Vfend
Viadur
Viagra
Vicoprofen
Vidarabine
Vidaza
Videx
Vigabatrin
Viloxazine
Vinblastine
Vincristine
Vinorelbine
Viomycin
Vioxx
Viracept
Viread
Visine
Vistide
Visudyne
Vitaped
Vitrase
Vivelle
Volmax
Voltaren
Voriconazole
Vosol
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


PATHOLOGIC MYOPIA
From Optometric Management, 9/1/05 by Angelilli, Allison

Demographics

* Age range at presentation: 50 years and older

* Gender trends: None

* Racial trends: None

* Refractive error trends: High myopia

* Associated medical conditions: None

Symptoms

* Patients may experience slow, progressive loss of visual acuity or rapid vision loss in the case of exudation due to choroidal neovascularization (CNV) or retinal detachment.

Differential Diagnosis

* Age-related macular degeneration (AMD): Pathologic myopia and AMD may look similar, however, AMD is characterized by drusen and lacks significant peripapillary atrophy. In addition, patients with pathologic myopia are likely to be younger and have higher myopia.

* Angioid streaks: This condition may look similar to the lacquer cracks of myopia, however they are generally bilateral, dark in color and often emanate from the disks. Any CNV generally originates from the streaks themselves in this condition.

Manifestations

Myopic Macular Degeneration

Peripapillary chorioretinal atrophy and linear breaks in Bruch's membrane ("lacquer cracks") are characteristic findings. Choroidal vessels may be visible through the atrophie retinal pigment epithelium.

Management: Fundus photography and fluorcsccin angiography are necessary to document disease progression and to monitor for subretmal neovascularization that may be amenable to photocoagulation or photodynamic therapy with verteporfin (Visudyne).

Subretinal Neovascularization

Ingrowth of new vessels from the choroid into the subretinal space is the most important change that predisposes patients to macular scarring and irreversible vision loss. If fundus examination reveals subretinal blood, exudates or a grayish-green choroidal lesion, the likelihood of CNV is high.

Management: Fluorescein angiography helps identify and locate the neovascularization site. Because of frequent close proximity to the center of the fovea in this population, verteporfin therapy is often the treatment of choice. Rapid referral for diagnosis and treatment is necessary.

Fuch's Spot

This characteristic lesion, which may be associated with subretinal neovascularization, appears in the later stages of pathologic myopia as a raised, circular and pigmented area in the macula.

Management: Fundus photography and fluorescein angiography are necessary to document disease progression as well as monitor for subretinal neovascularization development.

Rhegmatogenous Retinal Detachment

Chorioretinal atrophy, increased axial length and vitreoretinal traction increase the risk of breaks and detachments in normal and affected areas of retina.

Lattice degeneration, representing thinned areas of peripheral retina due to chronic traction by the vitreous, is a sign of increased risk of detachment.

Management: Scierai buckling or pneumatic retinopexy are the two most common and effective surgical techniques for repairing this type of retinal detachment. Rapid referral for management is critical as surgical success increases with the promptness of treatment.

Copyright Boucher Communications, Inc. Sep 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Visudyne
Home Contact Resources Exchange Links ebay